A Prevention Trial of Canakinumab in Subjects at High Risk for Lung Cancer
Clinical trial NCT05725343 · TERMINATED
Trial details
- NCT number
- NCT05725343
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-03
- Primary completion
- 2022-04-03
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.